Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban.
Floris T M BoschFrits I MulderMenno V HuismanJeffrey I ZwickerMarcello Di NisioMarc CarrierAnnelise SegersPeter VerhammeSaskia MiddeldorpJeffrey I WeitzMichael A GrossoAnil DuggalHarry R BüllerTzu-Fei WangDavid GarciaPieter Willem KamphuisenGary E RaskobNick van EsPublished in: Journal of thrombosis and haemostasis : JTH (2021)
Advanced cancer and low hemoglobin levels were associated with an increased risk of gastrointestinal bleeding in patients with gastrointestinal cancer receiving edoxaban. We were unable to identify other risk factors, mainly due to limited statistical power.